PRTN3 and rheumatoid arthritis: The presence of disease specific AutoAbs (notably anti citrullinated protein antibodies, ACPA) prior to disease development remains the best-known risk-factor,7 8 although it is also the main biomarker used to recruit most at-risk cohorts, (including arthralgia and first degree relationship to RA patients).